The shortage of Eli Lilly’s (LLY) blockbuster diabetes and weight loss drugs is officially over, according to the U.S. Food ...

The effectiveness can vary based on the individual response and adherence to treatment. Research indicates that GLP-1 ...

The FDA says the shortage of tirzepatide injection — a glucagon-like peptide 1 medication used for diabetes and weight loss — ...

A woman who started taking a popular weight loss medication through a clinical trial had to look for alternatives when her ...

KetoFuse is a supplement that helps speed up the metabolism and keep users in ketosis to support rapid calorie-burning and ...

The vehicles are fully electric, which means a sharp reduction in air and noise pollution, as well as lowering the reliance ...

Eli Lilly & Co.’s blockbuster weight-loss and diabetes drugs are no longer considered to be in shortage in the U.S., ...

An emerging market for compounded weight loss injections that mimic brand-name drugs such as Ozempic, Wegovy, Mounjaro and ...

In a phased rollout, the jabs eventually will be offered to those with a BMI of 35 or more and weight-related health problems ...

Kelly Osbourne has given fans an almighty surprise after unveiling a brand new ‘feminine’ look following a rapid weight loss ...

Despite launching on “Thursday Night Football,” the platform is about more than just ads and will fuel customer experiences ...

NHS says a quarter of a million people will be offered tirzepatide - brand name Mounjaro - after trials showed it helped obese participants lose a fifth of their body weight ...